Loading stock data…
Loading stock data…
US$0.26
Get one email when IGC crosses your level. Checked every 15 minutes during market hours.
▲ +0.00 (1.17%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
34.9
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.01
Bearish momentumMACD below its signal line (-0.00).
50-day average
0.28
Price belowShort-term trend reference.
200-day average
0.31
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
IGC Pharma Inc. is a pharmaceutical and biotechnology company focused on the development and commercialization of innovative therapies for the treatment of chronic pain, cancer, and other life-altering conditions. The company's primary role involves leveraging unique approaches to drug development, particularly using cannabinoids, to create novel solutions that address unmet medical needs. IGC Pharma operates within the biotech sector, which is marked by significant research and development acti…
igcpharma.com1 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (6 analysts, 2026-07-01)
1 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (6 analysts, 2026-06-01)
1 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (6 analysts, 2026-05-01)
1 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (6 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-15 | -0.02 | -0.02 | ✓ Beat |
| 2026-04-24 | 1.56 | 1.59 | ✓ Beat |
| 2025-11-14 | -0.02 | -0.02 | ✓ Beat |
| 2025-09-29 | -0.18 | -0.11 | ✓ Beat |
| 2025-08-14 | -0.02 | -0.02 | ✓ Beat |
| 2025-06-27 | -0.02 | -0.01 | ✓ Beat |
| 2025-02-14 | -0.03 | -0.02 | ✓ Beat |
| 2024-11-12 | -0.03 | -0.02 | ✓ Beat |
Companies in the same industry, via Finnhub